A collaborative comparison of international pediatric diabetes registries

Stefanie Lanzinger1,2, Anthony Zimmermann3, Ajenthen G Ranjan4,5

  • 1Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Germany.

Pediatric Diabetes
|May 13, 2022
PubMed

Insights

International pediatric diabetes registries, including SWEET, offer valuable data for type 1 diabetes research. These collaborations enhance global understanding and quality improvement in childhood diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Epidemiology
  • Health Services Research

Background:

  • Type 1 diabetes affects an estimated 1.1 million children and adolescents globally.
  • Seven major pediatric diabetes registries and the SWEET initiative collaborated for an international perspective.

Purpose of the Study:

  • To compare characteristics and data of leading pediatric diabetes registries.
  • To identify common objectives and differences in registry methodologies.
  • To facilitate future collaborations and the development of new registries.

Main Methods:

  • Data extraction from eight initiatives (seven registries + SWEET) up to December 31, 2020.
  • Analysis of registry characteristics, patient demographics, data availability, and completeness.
  • Comparison of objectives, data collection, and reporting practices.

Main Results:

  • Collectively, the initiatives cover over 900 centers and approximately 100,000 pediatric patients, primarily with type 1 diabetes.
  • Common goals include monitoring outcomes, quality improvement, and facilitating research.
  • Key differences noted in pediatric population definitions, adult inclusion, CGM data, and data linkage.

Conclusions:

  • Registries provide crucial open benchmarking and regularly updated data.
  • The collaborative effort highlights the value of standardized data for improving pediatric diabetes care.
  • This comparison encourages further international cooperation and the establishment of new registries.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
International Nursing Organizations I01:23

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
1.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
422
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K